Table 1 Baseline characteristics of patient cohorts included in model development and analysis.
HU-RES (N = 733) | NON-RES (N = 571) | Overall (N = 1304) | |
|---|---|---|---|
Gender, n (%) | |||
Female | 307 (41.9) | 328 (57.4) | 635 (48.7) |
Male | 426 (58.1) | 243 (42.6) | 669 (51.3) |
Age at index (years), mean (SD) | 68.4 (11.2) | 71.2 (10.8) | 69.6 (11.1) |
History of TE, n (%) | |||
Yes | 107 (14.6) | 93 (16.3) | 200 (15.3) |
No | 626 (85.4) | 478 (83.7) | 1104 (84.7) |
Number of phlebotomies (annualized), mean (SD) | 0.74 (1.44) | 0.28 (0.77) | 0.54 (1.22) |
ANC (×109/L), mean (SD) | 9.58 (6.00) | 8.36 (5.58) | 9.05 (5.85) |
HCT (%), mean (SD) | 49.0 (7.40) | 47.2 (7.37) | 48.2 (7.43) |
HGB (g/dl), mean (SD) | 15.6 (2.61) | 15.4 (2.49) | 15.5 (2.56) |
NLR, mean (SD) | 6.72 (6.37) | 6.06 (5.83) | 6.43 (6.15) |
RDW (%), mean (SD) | 18.1 (3.22) | 17.1 (3.05) | 177 (3.18) |
WBC (×109/L), mean (SD) | 13.1 (9.02) | 11.1 (6.36) | 12.3 (8.03) |
